NanoViricides files annual report on Form 10-K
PremiumThe FlyNanoViricides files annual report on Form 10-K
6M ago
NanoViricides says made ‘significant progress’ in NV-387 regulatory advancement
Premium
The Fly
NanoViricides says made ‘significant progress’ in NV-387 regulatory advancement
6M ago
NanoViricides plans to advance NV-387 into Phase II clinical trials
Premium
The Fly
NanoViricides plans to advance NV-387 into Phase II clinical trials
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
10M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
10M ago
NanoViricides engages Aagami to seek licensing, partnering opportunities
Premium
The Fly
NanoViricides engages Aagami to seek licensing, partnering opportunities
10M ago
NanoViricides reports ‘progress’ on NV-CoV-2 clinical trial
PremiumThe FlyNanoViricides reports ‘progress’ on NV-CoV-2 clinical trial
2y ago
NanoViricides signs license agreement with Karveer Meditech
Premium
The Fly
NanoViricides signs license agreement with Karveer Meditech
2y ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100